Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  5.00 10:06 AM EDT  
    Day High 5.29 04:00 PM EDT
    Range 0.29  
    Volume 1.10 M  
    30-Day Avg Vol 1.36 M
    Difference -19.20%  
    Market Cap 399.63 M  
    Mkt Cap Chg -22.99 M  
    Shares Out 79.29 M  
    % Shrs Traded 1.39%  
    1yr EPS Est 0.762  
    52-Wk Low 3.29 3/3/09
    52-Wk High 9.65 7/30/08
    Range 6.36  
    Prev Close 5.33 7/1/09  
    Today's Open 5.29  
    Change -0.75%
    Dividend (TTM)  
    Div Yield (TTM)
    Ex-Div Date
    Div Date
    Short Interest 9.08 M

    Performance Details

    Revenue (LFY) 110.18 M  
    Earnings (LFY) 29.20 M  
    Earnings (MRQ) 11.94 M  
    Next Earn Est 0.178  
    Next Earnings 08/10/2009
    EPS (TTM) 0.56  
    1yr EPS Growth 1.60%  
    P/E Ratio (TTM) 8.26  
    P/E Ratio (Fwd) 6.60  
    PEG Ratio 0.43  
    Return on Equity 23.02  
    Beta 1.86  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: AOB

    Blogs are not currently available for aob.

    View all blogs at BloggingStocks.

  • Related Information: AOB

    Company Overview: AOB

    American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 20 plant-based pharmaceuticals and nutraceuticals based on Traditional ... View Full Description

    Earnings Analysis: AOB

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.178 8/10/09
    Last Quarter 0.118 3/31/09 0.11 3/31/09 -0.008
    Missed
    2 Quarters Ago 0.25 12/31/08 0.25 12/31/08 0.00
    Met

    Financials: AOB

      Quarterly - 09/30/2007 Annual - 2006
    Total Revenue 43.51 M 110.18 M
    Gross Profit 30.30 M 68.51 M
    Operating Income 13.98 M 36.38 M
    Net Income 11.94 M 29.20 M